Bladder cancer stage III – Diagnostics

Go back

Diagnosing stage III bladder cancer involves a series of tests that help doctors understand how far the cancer has spread beyond the bladder wall. This stage is considered locally advanced, meaning the cancer has grown through the muscle layer into the surrounding fat tissue and may have reached nearby organs or lymph nodes, but has not yet spread to distant parts of the body.

Introduction: Who Should Undergo Diagnostics

If you notice certain warning signs, it’s important to seek medical attention promptly. The most common early symptom that should prompt you to see a doctor is blood in your urine, which doctors call hematuria. This blood may make your urine look pink, red, or brown, or it might only be visible under a microscope during routine testing.[1]

You should also consider getting checked if you experience frequent urination, a sudden urge to urinate even when your bladder isn’t full, or pain or burning during urination. These symptoms can feel similar to a urinary tract infection, but they deserve medical evaluation, especially if they don’t improve with treatment for infection.[8]

By the time bladder cancer reaches stage III, you might notice more advanced symptoms. These can include an inability to urinate, unexplained weight loss, loss of appetite, persistent lower back pain on one side, unusual weakness and fatigue, swelling in your feet, or bone pain. If you experience any combination of these symptoms, especially along with blood in your urine, you should seek medical care without delay.[1][8]

It’s worth knowing that these symptoms are not specific to bladder cancer alone. They can also be caused by more common conditions such as bladder stones, an enlarged prostate in men, or an overactive bladder. However, because early detection matters significantly for treatment outcomes, it’s always better to get checked rather than wait.[8]

⚠️ Important
Many symptoms of bladder cancer overlap with those of less serious conditions like urinary tract infections or bladder stones. However, blood in the urine should never be ignored, even if it appears only once or doesn’t cause pain. Always consult a doctor if you notice this symptom, as early diagnosis can make a significant difference in treatment success.

Diagnostic Methods for Stage III Bladder Cancer

When you visit a doctor with symptoms that might suggest bladder cancer, several tests will help determine whether cancer is present and, if so, how far it has spread. The diagnostic process typically begins with simpler tests and progresses to more detailed examinations if cancer is suspected.

Cystoscopy and Tissue Examination

The most important initial procedure is called a cystoscopy. During this examination, your doctor inserts a thin tube with a camera on the end through your urethra (the tube through which urine leaves your body) to look inside your bladder. This allows the doctor to see any tumors or abnormal areas directly. The procedure may feel uncomfortable, but it’s usually done with local numbing medication to reduce discomfort.[4]

If the doctor sees anything suspicious during the cystoscopy, they will often perform what’s called a transurethral resection of bladder tumor, or TURBT. This procedure removes a sample of the abnormal tissue so it can be examined under a microscope. The TURBT serves a dual purpose: it provides tissue for diagnosis and also removes as much of the visible tumor as possible.[4][6]

Sometimes a second TURBT is needed. This might happen if too much time has passed since the first procedure, or if the first sample didn’t include enough of the deeper muscle layer to determine exactly how far the cancer has spread. This repeat procedure helps ensure that doctors have all the information they need to stage the cancer accurately.[6]

Imaging Tests

Once bladder cancer is confirmed, imaging tests help doctors see how far the cancer has spread. These tests create detailed pictures of your body’s internal structures without the need for surgery.

A CT scan (computed tomography scan) uses X-rays taken from many angles to create cross-sectional images of your body. This test can show whether cancer has spread into the fatty tissue around your bladder or to nearby organs and lymph nodes. You may need to drink a contrast liquid or receive contrast material through an IV to make the images clearer.[4]

Your doctor might also order an MRI scan (magnetic resonance imaging), which uses magnets and radio waves instead of X-rays to create detailed pictures. MRI scans are particularly good at showing soft tissues and can help determine the exact depth of cancer invasion into the bladder wall and surrounding structures.[4]

Some medical centers may use PET scans (positron emission tomography) in certain situations. These scans involve injecting a small amount of radioactive sugar into your bloodstream. Cancer cells, which use more energy than normal cells, absorb more of this sugar and show up as bright spots on the scan. This can help identify cancer that has spread to lymph nodes or other areas.[4]

Understanding the TNM Staging System

After all the tests are completed, doctors use a system called TNM to describe how advanced the cancer is. Understanding this system can help you make sense of your diagnosis.

The “T” stands for tumor and describes how deeply the cancer has grown into the bladder wall and nearby tissues. In stage III bladder cancer, the T classification is usually T3 or T4a. T3 means the cancer has grown through the muscle layer into the fatty tissue surrounding the bladder. This can be visible only under a microscope (T3a) or visible on imaging tests (T3b). T4a means the cancer has spread into nearby organs like the prostate, uterus, or vagina.[3][4]

The “N” stands for nodes and refers to lymph nodes, which are small bean-shaped structures that help fight infection. Cancer can spread to lymph nodes in the pelvis. In stage III bladder cancer, the N classification might be N0 (no cancer in lymph nodes), N1 (cancer in one lymph node), N2 (cancer in more than one lymph node), or N3 (cancer in lymph nodes near the major blood vessels of the pelvis).[3][4]

The “M” stands for metastasis, which means distant spread. For stage III bladder cancer, M is always M0, meaning the cancer has not spread to distant organs like the lungs, liver, or bones. If cancer has spread to distant sites, it would be classified as stage IV rather than stage III.[3]

Additional Laboratory Tests

Your doctor will likely order blood tests to check your overall health and how well your kidneys are functioning. These tests don’t diagnose bladder cancer directly, but they help your medical team understand whether you’re healthy enough for certain treatments and whether the cancer has affected your kidney function.[8]

A complete urinalysis will examine your urine for blood, infection, and abnormal cells. While this test alone cannot diagnose bladder cancer, it provides important supporting information.[8]

Diagnostics for Clinical Trial Qualification

If you’re considering participating in a clinical trial, you may need additional or repeated diagnostic tests. Clinical trials are research studies that test new treatments, and they often have strict requirements about who can participate.

Most clinical trials require confirmation of your cancer stage through both tissue examination and imaging. This means you’ll need to have had a recent cystoscopy with biopsy, and the tissue samples will need to be reviewed to confirm that you have stage III disease. The biopsy must show that the cancer has grown through the muscle layer but hasn’t spread to distant organs.[4]

Imaging tests are essential for clinical trial enrollment. You’ll typically need recent CT scans or MRI scans showing the extent of the tumor and whether it has spread to lymph nodes or nearby organs. These images help researchers ensure that participants meet the specific criteria for the study. Some trials may require specific types of scans or may need scans to be performed at particular intervals.[4]

Blood tests play an important role in determining eligibility for clinical trials. Researchers need to know that your kidneys, liver, and bone marrow are functioning well enough to handle the treatments being studied. Tests measuring kidney function are particularly important because many bladder cancer treatments can affect the kidneys. You’ll need blood counts to ensure you have enough red blood cells, white blood cells, and platelets.[8]

Some clinical trials test treatments that target specific genetic changes in cancer cells. If you’re being considered for such a trial, your tumor tissue may be tested for particular genetic mutations. For example, some targeted therapies work only in tumors with mutations in genes called FGFR2 or FGFR3. Testing for these mutations requires special laboratory analysis of your biopsy tissue.[6][11]

You may also need tests to evaluate your overall physical condition. Some trials use a system called performance status to measure how well you’re able to carry out daily activities. Your doctor will assess whether you can take care of yourself, whether you’re able to be up and about most of the day, and how much assistance you need. This helps determine whether you’re well enough to participate in the trial.[4]

⚠️ Important
If you’re interested in clinical trials, ask your doctor about them early in your diagnostic process. Some trials require that certain tests be performed before any treatment begins, while others may accept patients who have already started treatment. Having fresh biopsy tissue and recent imaging can make it easier to enroll in trials quickly if you decide to participate.

Prognosis and Survival Rate

Prognosis

The outlook for stage III bladder cancer depends on several factors. How deeply the cancer has grown into surrounding tissues, whether it has spread to lymph nodes, and your overall health all influence your prognosis. Stage III bladder cancer is considered locally advanced, meaning it has spread beyond the bladder muscle but hasn’t reached distant organs. While this is a serious diagnosis, many people with stage III disease can be treated successfully.[1]

Your response to treatment is one of the most important factors affecting your outcome. Some patients achieve what doctors call a complete response, meaning no cancer can be detected after treatment. These patients often have better long-term outcomes than those whose cancer doesn’t respond as well to initial therapy.[9]

The general health condition of the patient plays a significant role in determining treatment options and prognosis. Patients who are well enough to undergo major surgery and chemotherapy generally have more treatment options available. Age itself is less important than overall fitness and the absence of other serious medical conditions.[9]

Bladder cancer, particularly the non-muscle invasive type, has a high rate of coming back even after successful treatment. Evidence suggests that up to 70% of certain bladder cancers may return within two years of treatment. This makes regular follow-up examinations extremely important. However, stage III disease that responds well to treatment can be controlled for many years in some patients.[19]

Survival rate

The five-year survival rate for stage III bladder cancer is approximately 39%. This means that about 39 out of 100 people diagnosed with stage III bladder cancer are still alive five years after diagnosis. It’s important to understand that this is a statistical average based on large groups of patients, and individual outcomes can vary significantly.[1]

These survival statistics come from data collected over many years, so they may not reflect the most recent advances in treatment. New therapies, including immunotherapy and targeted treatments, are continually being developed and may improve outcomes for people diagnosed today compared to those diagnosed several years ago.[1]

Survival rates can also differ based on whether the cancer has spread to lymph nodes. Patients whose cancer is confined to the bladder wall and surrounding tissue, without lymph node involvement, generally have better outcomes than those with cancer in their lymph nodes. However, even patients with lymph node involvement can achieve long-term survival with appropriate treatment.[4]

Ongoing Clinical Trials on Bladder cancer stage III

  • Study on Pre-Operative Nivolumab and Relatlimab for Adults with Stage II-IIIa Muscle-Invasive Bladder Cancer

    Recruiting

    4 1 1 1
    Investigated drugs:
    The Netherlands

References

https://www.healthline.com/health/stage-3-bladder-cancer

https://www.cancer.gov/publications/dictionaries/cancer-terms/def/stage-iii-bladder-cancer

https://www.cancerresearchuk.org/about-cancer/bladder-cancer/types-stages-grades/stages

https://www.mybladdercancerteam.com/resources/stage-3-bladder-cancer-survival-rate-symptoms-and-more

https://www.mskcc.org/cancer-care/types/bladder/diagnosis/stages

https://cancer.ca/en/cancer-information/cancer-types/bladder/treatment/stage-2-and-3

https://www.vacancer.com/cancer/bladder-cancer/stage-iii-bladder-cancer/

https://www.medicalnewstoday.com/articles/stage-3-bladder-cancer

https://hoapb.com/types-of-cancer/bladder-cancer/stage-ii-bladder-cancer/

https://www.cancer.gov/types/bladder/treatment/by-stage

https://cancer.ca/en/cancer-information/cancer-types/bladder/treatment/stage-2-and-3

https://www.cancer.org/cancer/types/bladder-cancer/treating/by-stage.html

https://www.mskcc.org/cancer-care/types/bladder/diagnosis/stages

https://www.healthline.com/health/stage-3-bladder-cancer

https://www.mayoclinic.org/diseases-conditions/bladder-cancer/diagnosis-treatment/drc-20356109

https://www.texasoncology.com/types-of-cancer/bladder-cancer/stage-ii-bladder-cancer

https://www.dana-farber.org/cancer-care/types/bladder-cancer/treatment

https://www.cancer.org/cancer/types/bladder-cancer/after-treatment/follow-up.html

https://www.cxbladder.com/us/blog/managing-life-after-bladder-cancer/

https://www.healthline.com/health/stage-3-bladder-cancer

https://www.mybladdercancerteam.com/resources/stage-3-bladder-cancer-survival-rate-symptoms-and-more

https://www.dana-farber.org/cancer-care/types/bladder-cancer/treatment

https://cancer.ca/en/cancer-information/cancer-types/bladder/treatment/stage-2-and-3

https://www.mayoclinic.org/diseases-conditions/bladder-cancer/diagnosis-treatment/drc-20356109

https://medlineplus.gov/diagnostictests.html

https://www.questdiagnostics.com/

https://www.healthdirect.gov.au/diagnostic-tests

https://www.who.int/health-topics/diagnostics

https://www.nibib.nih.gov/science-education/science-topics/rapid-diagnostics

https://www.yalemedicine.org/clinical-keywords/diagnostic-testsprocedures

https://www.health.harvard.edu/diagnostic-tests-and-medical-procedures

FAQ

How painful is a cystoscopy?

Most patients describe cystoscopy as uncomfortable rather than painful. You’ll typically receive local numbing medication before the procedure. You might feel pressure or a strong urge to urinate during the examination, but these sensations are temporary. Some people experience mild burning during urination for a day or two afterward.[4]

Can stage III bladder cancer be detected without blood in the urine?

Yes, though blood in urine is the most common first symptom, some people with stage III bladder cancer are diagnosed after experiencing other symptoms such as frequent urination, inability to urinate, unexplained weight loss, or persistent back pain. However, by stage III, most patients will have had blood in their urine at some point, even if they didn’t notice it.[1][8]

Why do I need so many different scans for diagnosis?

Different imaging tests provide different types of information. CT scans are excellent for seeing whether cancer has spread to lymph nodes or other organs. MRI scans provide detailed pictures of soft tissues and help determine exactly how deeply cancer has grown into the bladder wall. Your doctor chooses specific tests based on what information is most important for planning your treatment.[4]

What does it mean if my doctor orders a second TURBT procedure?

A second TURBT doesn’t necessarily mean your cancer is worse. Doctors often perform a repeat procedure to ensure they have removed all visible tumor and obtained a complete tissue sample that includes the muscle layer. This helps them stage the cancer more accurately. If significant time has passed since the first TURBT, a second procedure ensures the staging information is current.[6]

How often will I need follow-up tests after treatment?

Follow-up schedules vary depending on your specific situation and treatment, but bladder cancer requires regular monitoring because it can return. You’ll typically need cystoscopy examinations every few months initially, with the frequency decreasing over time if no cancer returns. Your doctor will create a personalized surveillance plan based on factors like how you responded to treatment and the characteristics of your cancer.[19]

🎯 Key takeaways

  • Blood in urine is the most common early warning sign of bladder cancer and should always be evaluated by a doctor, even if it occurs only once and doesn’t cause pain.
  • Cystoscopy with biopsy is the gold standard for diagnosing bladder cancer, allowing doctors to see inside the bladder and obtain tissue samples for microscopic examination.
  • Stage III bladder cancer means the tumor has grown through the muscle layer into surrounding fatty tissue or nearby organs, but hasn’t spread to distant parts of the body.
  • The TNM staging system helps doctors describe exactly how far cancer has spread by evaluating the tumor depth (T), lymph node involvement (N), and distant metastasis (M).
  • Multiple imaging tests like CT scans and MRI scans work together to give doctors a complete picture of cancer spread throughout your body.
  • Clinical trials may require additional diagnostic tests and genetic testing of tumor tissue to determine if you qualify for experimental treatments.
  • The five-year survival rate for stage III bladder cancer is about 39%, though individual outcomes vary widely based on treatment response and overall health.
  • Regular follow-up after treatment is essential because bladder cancer can return, with some types showing recurrence rates as high as 70% within two years.